Ischemic stroke Hemorrhagic stroke TIA (transient ischemic attack ) patiens Healthy (control) group apelin 13 cerebrovascular disease hemorrhagic stroke ischemic stroke transient ischemic attack
Conditions
Interventions
Blood samples were assessed for both patient groups (n:100
ischemic stroke, non-traumatic cerebral hemorrhage, and transient ischemic attack) and control groups (n:100
healthy volunteers). Diagnostic evaluation was performed in terms of blood Apelin 13 levels. The study was conducted for diagnostic purposes and did not have a treatment purpose. No computerised tomog
Experimental No treatment
Blood sample (diagnostic purpose)
Sponsors
Selcuk University Faculty of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. patients have been diagnosed with ischemic stroke, non-traumatic cerebral hemorrhage and transient ischemic attack in the emergency department within the first 24 hours of the onset of symptoms. 2. healthy volunteers.
Exclusion criteria
Exclusion criteria: 1. Individuals under 18 years of age, 2. Pregnant women were excluded from the study, 3. Acute myocardial infarction, 4. Pulmonary embolism, 5. Deep vein thrombosis, 6. Head trauma, 7. Heart failure, 8. Sepsis, 9. Cerebral edema, 10. Hypertensive encephalopathy, 11. Hypoglycemia, 12. Hepatic encephalopathy, 13. Serum electrolyte disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ischemic stroke At first admission Diffusion weighted Magnetic Resonance Imaging (MRI) | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemorrhagic stroke At first admission Computerised Tomography (CT) | — |
Countries
Turkey
Contacts
Public ContactBurak Erdem
Selcuk University Medical Faculty
Outcome results
None listed